The control group
The patients in the control group received routine
pain treatment consisting of epidural infusion
of 12 mg ropivacaine and 6 micrograms sufentanil
per hour and supplementary 10 mg ropivacaine at
break-through pain.
The control group was mobilized once daily and
followed the routine rehabilitation for inpatients,
aiming to discharge after eight days